Mandate

Vinge advises Investor on Agnafit Bidco’s public offer for Sobi

September 02, 2021 Capital Markets and Public M&A

Agnafit Bidco has announced a public offer to the shareholders of Swedish Orphan Biovitrum AB (publ).

The total value of the offer is approximately SEK 69.4 billion.

Vinges team mainly includes public M&A partner Erik Sjöman that advises Investor AB (publ), Sobi’s largest shareholder.

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025

Vinge advises Baseload Capital in connection with an investment from Google

Vinge has advised Baseload Capital Holding AB in connection with securing an investment from Google.
April 16, 2025